Tongue Cancer Treatment

Tongue cancer is a form of head and neck cancer that arises in the tissues of the tongue, a highly mobile and muscular organ essential for tasting, chewing, swallowing and speaking. Cancer may develop in the oral tongue (front two-thirds) or the base of the tongue, which lies deeper in the throat and is part of the oropharynx. Each type behaves differently and requires a distinct treatment strategy. The majority of cases are squamous cell carcinomas, originating in the thin, flat cells that line the tongue’s surface.

Scientists have determined that tongue cancer develops when genetic changes disrupt the normal cell life cycle, leading to uncontrolled growth and tumor formation. While the exact cause is not always clear, there are several well-established risk factors. Most notably, the use of tobacco—including cigarettes, cigars and smokeless tobacco products—is one of the most significant contributors. Heavy alcohol consumption can further amplify the risk. In recent years, human papillomavirus (HPV) infection has emerged as a major cause of cancers at the base of the tongue. Other risk factors include chronic tongue irritation, poor oral health and dietary deficiencies.

Early symptoms of tongue cancer can be subtle, which is why a prompt evaluation of any unusual or persistent changes is important. Common warning signs include a lump, thickened patch or nonhealing sore or ulcer on the tongue, unexplained bleeding, numbness and difficulty speaking or swallowing. Some patients may also notice changes in how their tongue moves or fits in their mouth. As the cancer progresses, it can spread to nearby lymph nodes, sometimes causing a neck lump or referred pain in the ear.

I'm alive today. I'm helping people and I have a lot of rewards from volunteering.

Ken

Tongue Cancer Survivor; Volunteer and Caregiver

In the United States, more than 54,000 people are diagnosed each year with cancers of the oral cavity and oropharynx. Historically, tongue cancer has always been more common in older adults, particularly men. However, HPV-related cases are shifting this trend, with increasing diagnoses among younger individuals who may not have traditional risk factors.

At Moffitt Cancer Center, tongue cancer care is available through our comprehensive Head and Neck Oncology Program. Our multispecialty team includes surgical oncologists, medical oncologists, radiation oncologists, reconstructive surgeons, speech-language pathologists and supportive care specialists, all working together to develop highly tailored treatment plans. Using advanced imaging, pathology evaluations and molecular testing, we gain a thorough understanding of each tumor’s characteristics, allowing for more precise and effective care. In treating tongue cancer, our primary objective is to remove the tumor completely while maintaining the mobility, sensation and structural integrity of the tongue whenever possible.

Surgery for tongue cancer

Surgery is often the foundation of treatment for tongue cancer, particularly for tumors located in the oral tongue. Because of the tongue’s complex role in daily function, surgical planning requires a high level of precision and coordination among specialists. At Moffitt, surgical oncologists are key members of the care team, working closely with reconstructive surgeons and rehabilitation specialists to ensure both effective tumor removal and an optimal functional outcome. When appropriate, we use minimally invasive techniques to reduce trauma to surrounding tissues and support a faster recovery.

When is surgery a treatment option for tongue cancer?

Surgical treatment may be recommended for early-stage or intermediate-stage tongue cancer if complete tumor removal is achievable. In this scenario, surgery is typically performed with a curative intent.

For a more advanced tumor, surgery may be incorporated into a combined treatment approach. For instance, it may be used to remove as much of the tumor as possible or to address residual cancer cells after other treatments are completed. The decision on whether to proceed with surgery will depend on several factors, including the size of the tumor, the depth of its invasion, any lymph node involvement and the potential effects of the procedure on speech and swallowing function.

What are the different types of tongue cancer surgery?

The recommended surgical approach will be tailored to the patient. Options may include:

• Glossectomy – Removal of part or all of the tongue to eliminate the tumor
• Neck dissection – Removal of lymph nodes to treat or prevent cancer spread
• Transoral robotic surgery (TORS) – A minimally invasive option for select tumors, particularly those located at the base of the tongue
• Reconstructive surgery – Restoration of the structure and function of the tongue following tumor removal

Each procedure is carefully planned to balance cancer control with function preservation.

What are the side effects and risks of surgery for tongue cancer?

Because the tongue is essential for eating and communication, the side effects of tongue cancer surgery are closely tied to how much tissue is removed. Possible side effects include:

• Changes in speech clarity or articulation
• Difficulty chewing or swallowing
• Reduced tongue mobility
• Swelling or stiffness in the neck
• Temporary or permanent numbness

At Moffitt, these side effects can be proactively managed through early rehabilitation, reconstructive techniques and ongoing supportive care. The patient will be closely monitored so that any challenges can be addressed quickly and effectively.

What is the recovery process like after surgery for tongue cancer?

Recovery can vary depending on the extent of surgery. Patients who undergo a relatively minor procedure may return home within a few days, while a more complex surgery involving reconstruction may require a longer hospital stay.

In the weeks following surgery, the patient may participate in speech or swallowing therapy to regain function. Dietary adjustments may be needed initially, followed by a gradual progression back to normal eating. Most patients see steady improvement over time, although full recovery can take several weeks to months.

Radiation therapy for tongue cancer

Radiation therapy often plays an important role in treating tongue cancer, either as a primary treatment or in combination with surgery and chemotherapy. At Moffitt, radiation oncologists work closely with medical physicists to ensure the precise delivery of radiation treatment while minimizing exposure to nearby healthy tissues.

How does radiation therapy treat tongue cancer?

Radiation therapy damages the DNA of cancer cells, preventing them from growing and dividing. For tongue cancer, it may be used to:

• Reduce the size of a tumor before surgery to make it easier to remove
• Destroy microscopic cancer cells that may remain after surgery
• Serve as the primary treatment in select cases
• Relieve symptoms of an advanced tumor

What radiation technologies are available for tongue cancer?

Advanced radiation delivery techniques available at Moffitt include:

• External beam radiation therapy (EBRT) – Uses an external machine (linear accelerator) to deliver targeted radiation beams to the tumor site and surrounding areas that may harbor microscopic cancer cells
• Intensity modulated radiation therapy (IMRT) – Enhances traditional EBRT by allowing the clinician to shape and adjust the intensity of the radiation beams, ensuring that the highest doses are directed at the tumor while reducing exposure to nearby structures, such as the salivary glands and jawbone
• Proton therapy – Enables heightened treatment precision, as proton beams can be controlled to stop at a specific point within the body, preventing the radiation from traveling beyond the tumor site
• Brachytherapy – Places a small radioactive source directly within or near a small, well-defined tumor

Among these technologies, proton therapy represents one of the most advanced radiation treatment options available for tongue cancer. By minimizing unnecessary radiation exposure to surrounding healthy tissues, proton therapy may help reduce treatment-related side effects while better preserving critical functions such as speech, swallowing and taste. This level of precision can be especially valuable for tumors located near sensitive structures in the head and neck, supporting both effective cancer treatment and long-term quality of life.

What side effects should I expect from radiation therapy for tongue cancer?

Possible side effects of radiation therapy for tongue cancer include:

• Difficulty swallowing
• Dry mouth
• Fatigue
• Skin irritation in the treated area
• Temporary changes in taste sensation

These side effects are typically manageable and improve after treatment ends. In the meantime, the healthcare team can provide individualized guidance and interventions to help minimize any discomfort.

What is the schedule and recovery timeline for radiation therapy for tongue cancer?

Radiation therapy is usually delivered daily, five days per week, for several weeks. Each session is carefully calibrated to maximize effectiveness while limiting exposure to healthy tissue. Side effects tend to build gradually during treatment and peak toward the end, then improve in the weeks following completion. In many cases, radiation therapy is incorporated into a comprehensive treatment plan for tongue cancer.

Chemotherapy for tongue cancer

Chemotherapy is a systemic treatment that uses powerful medications to destroy rapidly dividing cells throughout the body. At Moffitt, each chemotherapy regimen is customized based on the specific characteristics of the patient and the tumor, ensuring that treatment is both effective and aligned with the patient’s overall care plan.

When is chemotherapy used for tongue cancer?

To address tongue cancer, chemotherapy may be used in several ways:

• Before surgery to shrink the tumor and improve the likelihood of complete removal
• After surgery to help reduce the risk of recurrence
• In combination with radiation therapy (chemoradiation) to enhance the effectiveness of treatment
• As a primary treatment if surgery is not possible

The most appropriate approach will depend on several factors, including the stage and location of the tumor, whether it has spread and the patient’s overall health and treatment goals.

Which chemotherapy drugs are most effective for tongue cancer?

Standard chemotherapy agents for tongue cancer include:

• Cisplatin – One of the most commonly used chemotherapy drugs for head and neck cancers, cisplatin is often administered alongside radiation therapy to enhance the cancer-killing effects of treatment.
• Carboplatin – Similar to cisplatin but sometimes better tolerated, carboplatin may be recommended for a patient who cannot safely receive cisplatin due to certain side effects or an underlying health condition.
• 5-fluorouracil (5-FU) – Frequently used as part of a combined chemotherapy regimen, 5-FU interferes with cancer cell growth and division.
• Taxanes – Medications such as docetaxel and paclitaxel can disrupt cancer cell division and may be used with other chemotherapy agents for advanced or recurrent disease.

Depending on the patient’s diagnosis and treatment goals, these medications may be administered individually or as part of a multidrug regimen designed to improve treatment response and overall effectiveness. At Moffitt, chemotherapy plans are carefully personalized to balance cancer control with side effect management and quality of life.

What side effects are common with chemotherapy for tongue cancer?

Because chemotherapy targets rapidly dividing cells, it can also affect certain healthy cells in the body, particularly those in the mouth, digestive tract and bone marrow. As a result, many patients experience temporary side effects during treatment.

Common side effects of chemotherapy include:

• Fatigue
• Nausea and vomiting
• Mouth sores
• Changes in taste sensation
• Increased risk of infection due to lowered blood cell counts

Some patients may also experience reduced appetite or sensitivity in the mouth and throat, which can make eating and drinking more difficult during treatment. The severity and duration of the side effects can vary depending on the specific medications used, the dosage and the patient’s overall health.

At Moffitt, comprehensive supportive care is an important part of chemotherapy. Our patients have access to medications to control nausea and discomfort, hydration support to maintain strength and nutritional counseling to help manage eating challenges and ensure proper nourishment. The healthcare team will closely monitor the patients throughout treatment and can adjust the supportive strategies as needed to improve comfort and quality of life.

How will chemotherapy for tongue cancer affect my daily life and recovery?

Chemotherapy is typically administered in cycles, allowing time for recovery between active treatments. It may be delivered intravenously through a port or, in some cases, taken orally.

During chemotherapy, the patient may experience periods of fatigue or reduced energy, but may be able to maintain certain aspects of their normal routine. Most side effects gradually improve after treatment ends, with energy levels returning to normal over time.

Immunotherapy and targeted therapy for tongue cancer

When treating tongue cancer, Moffitt takes a precision medicine approach to identify all appropriate options, including advanced therapies tailored to the tumor’s unique genetic and molecular characteristics. By analyzing the tumor profile in detail, the healthcare team can determine whether immunotherapy, targeted therapy or a combination of treatments may provide the greatest benefit. These therapies are most commonly used for advanced, recurrent or metastatic tongue cancer, although ongoing research continues to expand their role in treatment.

How does immunotherapy work for tongue cancer?

Immunotherapy is designed to help the body’s immune system recognize and attack cancer cells more effectively. Some tongue cancers are able to avoid immune detection by using certain proteins to “hide” from the immune system. Immunotherapy drugs, particularly immune checkpoint inhibitors, work by blocking these signals and essentially “unmasking” the cancer cells so the immune system can identify and destroy them.

This treatment approach is often used for advanced or recurrent tongue cancer, especially when other therapies have not been successful. In some patients, immunotherapy can lead to a durable, long-term response while maintaining a different side effect profile than traditional chemotherapy.

Which biomarkers are tested for tongue cancer targeted therapy?

Targeted therapy focuses on the specific biological pathways and molecular changes that cancer cells rely on to grow and spread. To determine whether these therapies may be effective, genetic and molecular testing may be performed to evaluate biomarkers, such as:

• PD-L1 expression
• EGFR (epidermal growth factor receptor) alterations
• Other emerging molecular markers

The results of this testing can help guide treatment decisions and support a more individualized approach to care. By targeting specific abnormalities within the cancer cells, these therapies may help slow tumor progression while limiting unintended effects on healthy tissues.

What are the side effects of immunotherapy for tongue cancer?

The side effects of immunotherapy differ from those commonly associated with chemotherapy, mainly because they are related to increased immune system activity rather than direct effects on rapidly dividing cells. While many patients tolerate immunotherapy well, the treatment can sometimes cause the immune system to affect healthy tissues and organs. Common side effects include:

• Fatigue
• Skin changes, such as rash or itching
• Inflammation in certain organs, including the lungs, thyroid or intestines

Most side effects are manageable when identified early. The patient will be closely monitored throughout treatment, and the healthcare team will provide guidance on what symptoms to watch for and when to seek medical attention. Prompt management can often help minimize complications and allow treatment to continue safely.

Tongue cancer clinical trials at Moffitt

Clinical trials are an important part of cancer care at Moffitt, giving patients access to promising therapies and emerging treatment strategies that may not yet be widely available elsewhere. Through ongoing research, Moffitt’s specialists continue to evaluate new approaches to tongue cancer treatment, including novel drug combinations, next-generation immunotherapies, targeted therapies and advanced surgical and radiation techniques.

Participation in a clinical trial may be considered at various stages of treatment, from newly diagnosed cancer to recurrent or metastatic disease. Once enrolled, the patient will receive close monitoring from a specialized healthcare team while contributing to research that may help improve future standards of care.

Why should I consider a clinical trial for tongue cancer?

A clinical trial may offer several advantages, including:

• Access to a new treatment that is not yet widely available
• An opportunity to benefit from the latest research advancements in tongue cancer care
• Additional treatment options when standard therapies have been unsuccessful
• A chance to contribute to the ongoing advancement of cancer treatment and patient outcomes

Each clinical trial under consideration will be carefully reviewed to determine whether it is appropriate for the patient’s diagnosis, treatment history and overall health. The healthcare team will work closely with the patient to explain potential benefits, risks and eligibility requirements, helping them make informed treatment decisions with confidence.

Why choose Moffitt Cancer Center for tongue cancer treatment

Moffitt provides comprehensive, patient-centered care for individuals diagnosed with tongue cancer. In our dedicated Head and Neck Oncology Program, our patients can benefit from:

• The expertise of a multispecialty team
• Advanced surgical and radiation delivery techniques, including proton therapy
• A robust portfolio of clinical trials
• A full spectrum of rehabilitation and supportive care services

We develop highly tailored treatment plans with a strong emphasis on preserving function, minimizing side effects and improving quality of life. From diagnosis through recovery, Moffitt offers coordinated care and support every step of the way.

If you would like to explore your treatment options for tongue cancer with a specialist in our Head and Neck Oncology Program, you can request an appointment by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.